Zacks Places Share Value of ABVC BioPharma at $9.50
06 juil. 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, July 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Provides Vitargus® Update
30 juin 2022 08h30 HE
|
ABVC BioPharma, Inc.
Vitargus® Receives Phase II Thailand Central Research Ethics Committee Approval FREMONT, CA, June 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a...
ABVC BioPharma Expands Co-Development Partnership With Rgene Corporation
21 juin 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, June 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC
16 juin 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Announces Termination of Two Contracts
10 juin 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, June 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Announces Enrollment Progress for ADHD Phase II Part 2 Clinical Study
01 juin 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, June 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Engaged by Orion BioTech to Identify Global Licensing Partners
25 mai 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, May 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
Prestigious Researchers to Provide Consulting Services in Connection with ABVC BioPharma's Depression Medicines
23 mai 2022 07h30 HE
|
ABVC BioPharma, Inc.
Fremont, CA, May 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC Biopharma Reports First Quarter 2022 Financial and Operational Results
16 mai 2022 17h46 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire--ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Engages the FreeMind Group to Support Grant Funding
13 mai 2022 08h30 HE
|
ABVC BioPharma, Inc.
FREMONT, CA, May 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...